INCYTE CORP INCYTE ORD SHS (0J9P.L) Financials
0J9P.L Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | 6.4 billion | 1.5 billion |
2023-06-30 | 6.2 billion | 1.5 billion |
2023-03-31 | 5.8 billion | 1.3 billion |
0J9P.L Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | 136.9 million | 48.0 million |
2023-06-30 | 299.2 million | 54.5 million |
2023-03-31 | -117.5 million | 53.4 million |
0J9P.L Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 201.1 million |
2023-09-30 | 171.3 million |
2023-06-30 | 203.5 million |
2023-03-31 | 21.7 million |
0J9P.L Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | - |
2023-09-30 | 3.5 billion | - | - |
2023-06-30 | 3.4 billion | - | - |
2023-03-31 | 3.1 billion | - | - |
0J9P.L Shares Outstanding
0J9P.L Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | - | - | - |
2023-09-30 | 11.0 million | 387.0 million | - | - |
2023-06-30 | 7.3 million | 425.9 million | - | - |
2023-03-31 | 11.9 million | 407.2 million | - | - |
0J9P.L Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | 919.0 million | 436.9 million |
2023-06-30 | 954.6 million | 468.5 million |
2023-03-31 | 808.7 million | 462.1 million |
0J9P.L
Price: $57.12
52 week price:
Earnings Per Share: 4.20 USD
P/E Ratio: 13.82
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 115.8 million